This Article Full Text Full Text (PDF) All Versions of this Article: 90/3/1625    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chan, J. L. Articles by Mantzoros, C. S. Search for Related Content PubMed PubMed Citation Articles by Chan, J. L. Articles by Mantzoros, C. S. Related Collections Neuroendocrinology and Pituitary Obesity

Recombinant Methionyl Human Leptin Administration Activates Signal Transducer and Activator of Transcription 3 Signaling in Peripheral Blood Mononuclear Cells in Vivo and Regulates Soluble Tumor Necrosis Factor- Receptor Levels in Humans with Relative Leptin Deficiency

Division of Endocrinology, Diabetes, and Metabolism (J.L.C., S.J.M., J.B., K.H., Y.-B.K., B.B.K., C.S.M.) and Division of Immunology (X.L.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215

Address all correspondence and requests for reprints to: Christos S. Mantzoros, M.D., D.Sc., Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, ST 816, Boston, Massachusetts 02215. E-mail: cmantzor{at}bidmc.harvard.edu.

Studies of congenital complete leptin deficiency in animals and humans support a role for leptin in regulating immune function. Whether acquired relative leptin deficiency affects immunological parameters in healthy humans remains unknown. We thus used experimental models of relative leptin deficiency and recombinant methionyl human leptin (r-metHuLeptin) administration in humans to investigate whether r-metHuLeptin would activate signaling pathways in peripheral blood mononuclear cells (PBMCs) and whether acquired relative leptin deficiency and/or increasing circulating leptin levels into the physiologic range would change PBMC subpopulations and cytokines important in the T-helper cell and systemic immune responses. We found that r-metHuLeptin administration to healthy humans activates signal transducer and activator of transcription-3 signaling in PBMCs in vivo. Neither short-term leptin deficiency, induced by 3-d complete fasting, nor physiologic r-metHuLeptin replacement for the same period of time had a major effect on PBMC subpopulations or serum cytokines in healthy men. In contrast, normalizing serum leptin levels over 8 wk in lean women with relative leptin deficiency for 5.1 ± 1.4 yr (mean ± SE) due to chronic energy deficit increased soluble TNF receptor levels, indicating activation of the TNF system. These findings suggest that relative leptin deficiency due to more long-term energy deprivation is associated with defects in immunological parameters that may be corrected with exogenous r-metHuLeptin administration. Further studies are warranted to assess the implications of acquired relative hypoleptinemia and/or r-metHuLeptin administration on the immunosuppression associated with energy- and leptin-deficient states in humans.

This article has been cited by other articles:

				L. A. Viikari, R. K. Huupponen, J. S. A. Viikari, J. Marniemi, C. Eklund, M. Hurme, T. Lehtimaki, M. Kivimaki, and O. T. Raitakari Relationship between Leptin and C-Reactive Protein in Young Finnish Adults J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4753 - 4758. [Abstract] [Full Text] [PDF]

				J. L. Chan, S. L. Wong, C. Orlova, P. Raciti, and C. S. Mantzoros Pharmacokinetics of Recombinant Methionyl Human Leptin after Subcutaneous Administration: Variation of Concentration-Dependent Parameters According to Assay J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2307 - 2311. [Abstract] [Full Text] [PDF]

				A. Schaffler, U. Muller-Ladner, J. Scholmerich, and C. Buchler Role of Adipose Tissue as an Inflammatory Organ in Human Diseases Endocr. Rev., August 1, 2006; 27(5): 449 - 467. [Abstract] [Full Text] [PDF]

				J. L. Chan, G. Matarese, G. K. Shetty, P. Raciti, I. Kelesidis, D. Aufiero, V. De Rosa, F. Perna, S. Fontana, and C. S. Mantzoros Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans PNAS, May 30, 2006; 103(22): 8481 - 8486. [Abstract] [Full Text] [PDF]

				E. A. Oral, E. D. Javor, L. Ding, G. Uzel, E. K. Cochran, J. R. Young, A. M. DePaoli, S. M. Holland, and P. Gorden Leptin Replacement Therapy Modulates Circulating Lymphocyte Subsets and Cytokine Responsiveness in Severe Lipodystrophy J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 621 - 628. [Abstract] [Full Text] [PDF]

				B. Canavan, R. O. Salem, S. Schurgin, P. Koutkia, I. Lipinska, M. Laposata, and S. Grinspoon Effects of Physiological Leptin Administration on Markers of Inflammation, Platelet Activation, and Platelet Aggregation during Caloric Deprivation J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5779 - 5785. [Abstract] [Full Text] [PDF]